Northwest Wealth Management’s Biogen BIIB Stock Holding History

Northwest Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Buy	1,255 +103	+9%	+$19.7K	0.04%	211
2026 Q1	$211K	Buy	+1,152	New	+$212K	0.03%	238
2019 Q2	–	Sell	-104	Closed	-$25K	–	148
2019 Q1	$25K	Buy	104 +68	+189%	+$21.4K	0.02%	277
2018 Q4	$11K	Hold	36	–	–	0.01%	318
2018 Q3	$13K	Hold	36	–	–	0.01%	331
2018 Q2	$10K	Hold	36	–	–	0.01%	345
2018 Q1	$10K	Buy	+36	New	+$11.2K	0.01%	350

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Northwest Wealth Management's BIIB Position: Q2 2026 in Review

Northwest Wealth Management increased its Biogen (BIIB) stake by 8.9% in Q2 2026, buying an estimated $19.7K and bringing the position to 1,255 shares worth $271K. The position accounts for 0.04% of the portfolio, ranked #211.

Northwest Wealth Management first reported a position in BIIB in Q1 2018 and has held it in 7 quarters since. 369 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Northwest Wealth Management held 1,255 shares of Biogen worth $271K as of Q2 2026.
Northwest Wealth Management bought 103 Biogen shares in Q2 2026, an estimated $19.7K.
Biogen made up 0.04% of Northwest Wealth Management's portfolio in Q2 2026, its #211 holding.
Northwest Wealth Management first reported a position in Biogen in Q1 2018 and has held it in 7 quarters since.
369 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Northwest Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.